Corona vaccine from Biontech and Pfizer: "We distribute the vaccine fairly":
rp-online.de/panorama/coronavirus/corona-impfstoff-von-biontech-und-pfizer-wir-verteilen-den-impfstoff-gerecht_aid-54552893
Story Details
| Last Updated | Nov 12 20 |
| Total Articles | 5 |
News on this topic
How the corona vaccine should be distributed: The EU Commission wants to seal the contract with Biontech this Wednesday. Germany should get 38 million cans ...
augsburger-allgemeine.de/politik/Wie-der-Corona-Impfstoff-verteilt-werden-soll-id58517436.html
Vaccine against corona: the most important questions and answers: A vaccine against the coronavirus is expected to come onto the market this year ...
morgenpost.de/berlin/article230877656/Impfstoff-gegen-Corona-Die-wichtigsten-Fragen-und-Antworten.html
Coronavirus: Here medical experts answer your questions: Here you will find answers to your questions about Covid-19.
ksta.de/ratgeber/gesundheit/coronaexperten-36405100
More articles on this subject
Previous
How the corona vaccine should be distributed: The EU Commission wants to seal the contract with Biontech this Wednesday. Germany should get 38 million cans ...
augsburger-allgemeine.de/politik/Wie-der-Corona-Impfstoff-verteilt-werden-soll-id58517436.html
Vaccine against corona: the most important questions and answers: A vaccine against the coronavirus is expected to come onto the market this year ...
morgenpost.de/berlin/article230877656/Impfstoff-gegen-Corona-Die-wichtigsten-Fragen-und-Antworten.html
Coronavirus: Here medical experts answer your questions: Here you will find answers to your questions about Covid-19.
ksta.de/ratgeber/gesundheit/coronaexperten-36405100
Stefan Homburg: CDU Council invites Schwurbel professor to give a lecture: The CDU Economic Council invites you to a lecture with a professor who is notorious ...
t-online.de/nachrichten/deutschland/gesellschaft/id_100378778/stefan-homburg-cdu-rat-laedt-schwurbel-professor-zum-vortrag.html
Quick Glance: Stefan Homburg: Controversy Surrounding Lecture at Business Council
- The CDU's Business Council invites controversial Professor Stefan Homburg, known for spreading misinformation about Corona.
- Homburg, once a respected expert, faced criticism due to questionable statements during the pandemic.
- The decision to invite Homburg sparks outrage and criticism for his controversial views, especially upsetting cancer patients.
- The Business Council, a lobbying organization with ties to the CDU, faces scrutiny for organizing influential supporters and attracting backlash over the invitation.
Biontech's business collapses massively: buy shares cheaply now?: Corona is over, and the numbers and share price at vaccine manufacturer Biontech are collapsing ...
capital.de/geld-versicherungen/biontechs-geschaeft-bricht-massiv-ein--aktie-jetzt-guenstig-kaufen--34561014.html
Paid articlePaidQuick Glance: Biontech: Massive Business Decline Post-COVID
- As COVID ends, Biontech faces declining numbers and stock prices.
- A study reveals the significant impact of COVID on life expectancy.
- Biontech gained global recognition with the mRNA vaccine.
- The company is now focusing on new treatments for cancer to bounce back.
Pfizer vs Moderna battle over COVID vaccine patents begins in UK: Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-vs-moderna-battle-over-covid-vaccine-patents-begins-uk-2024-04-23/
mRNA pioneer: Biontech focuses on cancer therapies: The Mainz mRNA pioneer is doing well in the declining Corona business. However, the focus is clearly on the ...
faz.net/aktuell/wirtschaft/unternehmen/biontech-fokussiert-auf-krebstherapien-19599944.html
Quick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge
- BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.
- The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.
- BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.
- Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.
Biontech is probably in the red this year: Biontech could end a financial year with losses in 2024 for the first time since the pandemic ...
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-schreibt-dieses-jahr-wohl-rote-zahlen-3464126
Quick Glance: Biontech: Financial Situation and Product Portfolio
- Biontech is expected to slip into the red this year. Indications suggest that losses will be incurred.
- Biontech launched an immunization campaign half a year ago in Mainz with posters encouraging medical consultation.
- The company holds product aces, including vaccines and treatments combating diseases.
- The financial status reflects predicted losses despite an array of promising products.
Sick after coronavirus vaccination? Palatinate man goes to court: A man from Pirmasens takes Biontech to court. Because he has suffered serious damage to his ...
rheinpfalz.de/lokal/pirmasens_artikel,-krank-nach-corona-impfung-pf%C3%A4lzer-zieht-vor-gericht-_arid,5628342.html
Do the latest vaccines better protect us from COVID-19?: For the first time, Australian researchers have sought to put a number on how much better newer vaccines ...
smh.com.au/national/do-the-latest-vaccines-better-protect-us-from-covid-19-20240213-p5f4oj.html
Alleged vaccine damage: First proceedings opened in Hesse against Biontech: Vaccinated people all over Germany are suing pharmaceutical companies because of ...
faz.net/aktuell/rhein-main/frankfurt/corona-impfungen-verfahren-gegen-biontech-wegen-vermeintlicher-impfschaeden-19469214.html
Paid articlePaidQuick Glance: Lawsuit Against Biontech for Alleged Vaccine Injuries
- Vaccinated individuals across Germany are suing pharmaceutical companies for alleged vaccine injuries.
- The first lawsuit against Biontech in Hessen has commenced in Frankfurt.
- The Frankfurt Regional Court heard a civil lawsuit against vaccine manufacturer Biontech on Tuesday.
- Lawyers represent nearly 3000 cases of alleged vaccine injuries and lawsuits.
Heart damage due to coronavirus vaccination? Lawsuit against Biontech dismissed: One plaintiff claimed to have suffered health problems as a result of the ...
rnd.de/panorama/herzschaden-durch-corona-impfung-klage-gegen-biontech-abgewiesen-HINPVMMAQ5KPBBIK7472V4DVAU.html
Quick Glance: Lawsuit against Biontech Dismissed
- Woman sought 150,000 euros in damages from Biontech.
- Court rejects lawsuit over alleged vaccine injuries.
- Plaintiff claimed heart damage from vaccination.
- Landgericht Frankfurt rules against damages claim.
RKI doubted AstraZeneca for months: “Less perfect”, “not a sure-fire success”, “2-class vaccination”
fr.de/politik/rki-protokolle-robert-koch-institut-corona-coronavirus-impfung-astrazeneca-zr-92921607.html
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge: Low vaccination rates against the latest versions of COVID-19 and influenza are putting ...
reuters.com/business/healthcare-pharmaceuticals/who-sees-incredibly-low-covid-flu-vaccination-rates-cases-surge-2024-01-12/
CDC: Older adults should get COVID-19 booster shot: The recommendation comes ahead of a likely summer wave of COVID-19 infections that has occurred in past years ...
usatoday.com/story/news/health/2024/02/28/cdc-older-adults-covid-19-booster-shot/72779378007/
Older US adults should get another COVID-19 shot, health officials recommend: Federal health officials say older U.S. adults who got a COVID-19 shot in the fall ...
richmond.com/life-entertainment/nation-world/wellness/covid-booster-shot-update-cdc/article_7b348805-ecd4-5d08-933d-45329f806f32.html
Why are 1,500 Americans still dying from COVID every week?: Experts say some Americans aren't accessing available vaccines and treatments.
abcnews.go.com/Health/1500-americans-dying-covid-week/story
BioNTech co-founder Christoph Huber: “Threat was stylized instead of clarified” | Tyrolean daily newspaper online
tt.com/artikel/30874945/biontech-mitgruender-christoph-huber-bedrohung-wurde-stilisiert-statt-aufzuklaeren
COVID and beyond: labs unite to boost genomic surveillance globally: Two laboratories in Britain and South Africa, which were at the forefront of tracking new ...
reuters.com/business/healthcare-pharmaceuticals/covid-beyond-labs-unite-boost-genomic-surveillance-globally-2024-01-25/
WHO calls for world pandemic treaty to prepare for deadly 'Disease X': World Health Organization (WHO) Director-General Tedros Ghebreyesus has called on ...
foxnews.com/world/who-director-calls-for-world-pandemic-treaty-to-prepare-for-disease-x
Paul Offit looks back on COVID-19, misinformation, and how public health lost the public’s trust in new book
bostonherald.com/2024/03/08/paul-offit-looks-back-on-covid-19-misinformation-and-how-public-health-lost-the-publics-trust-in-new-book/
German biotechs: CureVac hits the brakes, BioNTech faces an important date: CureVac plans to cut 150 jobs to focus on broader product pipeline.
deraktionaer.de/artikel/pharma-biotech/deutsche-biotechs-curevac-tritt-auf-die-bremse-biontech-vor-wichtigem-termin-20353214.html
More pandemic-style price fixing won’t help global health: With COVID-19 no longer the public health emergency it once was, it’s a good time to rescind the TRIPS ...
thehill.com/opinion/healthcare/4489726-more-pandemic-style-price-fixing-wont-help-global-health/
Vaccination recommendations: How can the Stiko become faster, Mr. Meerpohl?: Stiko member Jörg Meerpohl explains why some vaccination decisions were so difficult ...
spiegel.de/gesundheit/diagnose/impf-empfehlungen-wie-kann-die-stiko-schneller-werden-joerg-meerpohl-a-60fbbe6c-4105-4d58-871b-ceace889358e
Paid articlePaid
Suffering from heart, brain disorders? Global study links COVID-19 vaccines with 13 medical conditions | Mint
livemint.com/science/health/suffering-from-heart-brain-disorders-global-study-links-covid-19-vaccines-with-13-medical-conditions-11708520855014.html
A new road for EU global health action: With the previous foundations of the EU’s approach to global health dating back to 2010, the European Commis
euractiv.com/section/health-consumers/news/a-new-road-for-eu-global-health-action/
DeSantis praises COVID-19 grand jury report, which some scientists criticize: Scientist disputes grand jury’s findings that interventions such as lockdowns and ...
tampabay.com/news/florida-politics/2024/02/10/florida-covid-19-vaccine-desantis-mandate-ladapo/
Paid articlePaid
What is 'Disease X' and why should we be taking it seriously?: While "Disease X" may sound like a "science fiction film ...
euronews.com/next/2024/01/19/what-is-disease-x-and-how-is-the-world-preparing-for-it
Lessons from Lower-Income Countries’ COVID-19 Vaccination Efforts | by Benjamin Schreiber, Richard Mihigo and Ann Lindstrand - Project Syndicate
project-syndicate.org/commentary/low-income-countries-must-tailor-vaccine-strategies-next-pandemic-by-benjamin-schreiber-et-al-2024-01
COVID vaccines saved at least 1.4 million lives in Europe, WHO says - Health - Life & Style
english.ahram.org.eg/NewsContent/7/48/516131/Life--Style/Health/COVID-vaccines-saved-at-least--million-lives-in-Eu.aspx
Desperate after Iowa bust, DeSantis spews — again — dangerous COVID vaccine quackery | Opinion
miamiherald.com/opinion/editorials/article284392370.html
Financing: German biotechs raise one billion euros: The lull after the Corona boom seems to be over: in 2023, German biotechs raised more money from investors ...
faz.net/aktuell/wirtschaft/unternehmen/deutsche-biotechs-mit-trendwende-nach-corona-flaute-die-aussichten-fuer-2024-19441743.html
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics